Your browser doesn't support javascript.
loading
Phase I study of pemetrexed with sorafenib in advanced solid tumors.
Poklepovic, Andrew; Gordon, Sarah; Shafer, Danielle A; Roberts, John D; Bose, Prithviraj; Geyer, Charles E; McGuire, William P; Tombes, Mary Beth; Shrader, Ellen; Strickler, Katie; Quigley, Maria; Wan, Wen; Kmieciak, Maciej; Massey, H Davis; Booth, Laurence; Moran, Richard G; Dent, Paul.
Afiliação
  • Poklepovic A; Departments of Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Gordon S; Departments of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Shafer DA; Departments of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Roberts JD; Departments of Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Bose P; Departments of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Geyer CE; Departments of Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia, USA.
  • McGuire WP; Departments of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Tombes MB; Current address: Department of Medical Oncology, Yale School of Medicine, New Haven, Connecticut, USA.
  • Shrader E; Departments of Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Strickler K; Departments of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Quigley M; Current address: Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Wan W; Departments of Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Kmieciak M; Departments of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Massey HD; Departments of Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Booth L; Departments of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Moran RG; Departments of Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Dent P; Departments of Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia, USA.
Oncotarget ; 7(27): 42625-42638, 2016 07 05.
Article em En | MEDLINE | ID: mdl-27213589
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Niacinamida / Pemetrexede / Neoplasias Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Niacinamida / Pemetrexede / Neoplasias Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article